OECD TG 410
OECD TG 410, OECD Test Guidelines for the Testing of Chemicals, Section 4 (Health Effects) within the framework of the standard ‘Repeated Dose Dermal Toxicity: 21/28-Day Study’, i.e. a 21/28-day study on repeated dermal toxicity. It was first adopted in 1981. The test is an in vivo toxicity study designed to evaluate the local and systemic toxic effects, target organs and dose-response relationship of a substance following repeated dermal application over a period of 21 or 28 days.
The basic principle of the test is as follows:
- The test substance is usually tested on rats; in accordance with regulatory requirements, rabbits or guinea pigs may also be used.
- The test substance is applied to a depilated, healthy area of skin (usually around 10 per cent of the body surface area) for approximately 6 hours each day under an occlusive or semi-occlusive dressing.
- Die Anwendung wird 21 oder 28 Tage lang, an 7 Tagen pro Woche oder gemäß dem behördlichen Protokoll wiederholt.
- As a rule, three dose groups and a control group are used; the dose levels are determined on the basis of preliminary trials or existing data. The high dose should produce toxic effects, but should not result in high mortality or excessive pain.
- As a rule, at least five animals of each sex are used in each group; additional animals may be included for blood and tissue analyses. A recovery group may be planned if necessary.
- The animals are clinically monitored on a daily basis; local skin changes (erythema, oedema, dryness, cracks, necrosis, etc.) at the application site are regularly documented.
- Body weight and feed and water intake are monitored regularly.
- At the end of the study, haematology, clinical chemistry and urinalysis tests are carried out.
- The weights of the organs are measured and a macroscopic post-mortem examination is carried out.
- A histopathological examination of the skin in the area of application and of the major organs is carried out.
The key parameters reported in the study are as follows:
- The doses administered (mg/kg body weight/day) and the administration conditions (duration, type of housing, area)
- Clinical observations and their onset
- Local skin findings in the area of application and their assessment
- Changes in body weight and feed/water intake
- Haematological parameters (complete blood count, white blood cell differential, etc.)
- Clinical chemistry parameters (liver and kidney function tests, electrolytes, glucose, lipids, etc.)
- Results of the urine analysis
- Organ weights (absolute and relative)
- Findings from the macroscopic post-mortem examination
- Histopathological findings (skin in the area of application and major organs)
- NOAEL/LOAEL values and dose-response relationship
- Data on measurement uncertainty and repeatability
What is the purpose of the examination?
OECD TG 410 is being carried out for the following scientific and regulatory purposes:
- Assessment of repeated dermal toxicity: determination of local and systemic toxic effects following 21-day and 28-day repeated dermal exposure
- Assessment of the dose-response relationship: determination of the NOAEL and LOAEL values
- Assessment of target organ toxicity: evaluation of histopathological changes in the liver, kidneys, the haematopoietic system and other organs
- Assessment of local skin effects: identification of irritation, corrosiveness or other skin changes in the area of repeated application
- Assessment of dermal exposure scenarios: provision of data, in particular for chemicals, pesticides, biocidal products and cosmetic ingredients where exposure via the skin is significant
- Support for regulatory dossiers: for use in safety assessments under REACH, for biocides, plant protection products, medicinal products and industrial chemicals
- Contribution to risk assessment: Provision of baseline data for risk assessment in scenarios involving repeated dermal exposure
- Evidence-based approach: a contribution to the holistic assessment of the substance in conjunction with other toxicological, physicochemical and exposure data
OECD Test Guideline 410 does not provide any direct information on acute toxicity, carcinogenicity or reproductive toxicity; these effects must be assessed in separate tests.
The results should be interpreted in the context of the chemical structure of the substance, data on dermal absorption, other toxicity studies and the exposure assessment.
As part of our nano-testing services, we carry out 21/28-day repeated-dose dermal toxicity studies in accordance with OECD TG 410 with scientific rigour, utilising our accredited laboratory facilities and quality management system. Our scope of services includes the following:
- Preparation of a study protocol in accordance with OECD TG 410
- Scientific justification for the dose levels, based on the physicochemical properties of the test substance and the available toxicity data
- Selection of a suitable carrier (vehicle) and assessment of solubility and stability
- Determination of species, sex, age, application site, type of covering and observation period
- Planning the control and treatment groups, the number of animals and, where applicable, a return group
- Compliance with ethical approval and animal welfare requirements
For information on study design, dose determination, application site and coverage planning, sample collection conditions, test schedule and reporting procedures for your 21/28-day repeated-dose dermal toxicity studies in accordance with OECD TG 410, please feel free to contact Nano-Test.

